Revolutionizing early cancer detection with cutting-edge science
Traditional cancer detection methods have faced challenges, lacking the required sensitivity and being expensive and complex. 4D Lifetec has taken a revolutionary approach, harnessing the power of DNA repair deficiency to create a highly standardized assay - 4D Lifetest™. This breakthrough test is designed to provide early detection for all cancer types using peripheral blood cells, such as PBMCs, as a sensitive biomarker.
Clinical validation studies are underway, focusing on breast, lung, prostate, and colon cancers. Collaborating with renowned cancer centers in Switzerland, we are working diligently to establish 4D Lifetest™ as the universal screening assay for early cancer detection in asymptomatic patients.
Join us on this transformative journey towards more effective therapies and improved patient outcomes. The future of cancer diagnostics has arrived - and it's powered by 4D Lifetest™